FDA Commissioner on Potential Mifepristone Restrictions and COVID Booster Recommendations

FDA's Stance on Mifepristone

• 🎯 The new FDA Commissioner, Dr. Marty Makary, stated he has no current plans to further restrict mifepristone.
• 💡 He emphasized that the FDA's actions are guided by incoming data, and they cannot promise not to act if new data reveals a significant signal.
• ⚠️ If new data emerges that contradicts previous findings on the safety and effectiveness of mifepristone, the FDA would need to evaluate the strength and reliability of that data.

COVID Booster Recommendations for Children

• 🔬 Commissioner Makary also indicated agreement that the federal government should reconsider its recommendation for COVID boosters for children.
• 📊 This stance comes amidst reports that HHS Secretary Robert F. Kennedy Jr. is considering such a reversal, despite previous panels deeming the boosters safe and beneficial for preventing severe illness in kids.